gMG Connect
  • Saved
Chronic mimics of myasthenia gravis: a retrospective case series - PubMed

Chronic mimics of myasthenia gravis: a retrospective case series - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36753801/

Myasthenia gravis often presents a diagnostic challenge and may be misdiagnosed, particularly in seronegative disease with active symptoms. We retrospectively evaluated 61 patients following the introduction of single fibre electromyography...


Conclusions: We found myasthenic mimics should be suspected in disease that is static and treatment refractory, and functional mimics in disease with frequent flares. Thorough neurophysiologic assessment is important, particularly when making a diagnosis of seronegative myasthenia gravis.


  • Saved
Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates - PubMed

Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36754834/

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....


Conclusions: Our study suggests that AChR autoantibodies are produced by nonmalignant, polyclonal B cells The new anti-CD20 treatment obinutuzumab might be considered in effectively treating AChR  MG.

  • Saved
Complement Activation Profiles in Anti-AChR Positive Myasthenia Gravis - PubMed

Complement Activation Profiles in Anti-AChR Positive Myasthenia Gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36752022/

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....


Conclusions: Markers indicative of complement activation are prominently increased in patients with AChR-Ab MG despite standard immunosuppressive therapies. Complement inhibition proximal to C5 cleavage should be explored for its potential therapeutic benefits in AChR-Ab MG.


  • Saved
Myasthenia gravis: Frequently asked questions

Myasthenia gravis: Frequently asked questions

Source : https://www.ccjm.org/content/90/2/103

Myasthenia gravis is a disorder of neuromuscular junction transmission, the result of antibodies against the post-synaptic aspect of the neuromuscular junction. Its clinical hallmark is fatigable weakness of skeletal muscles,...


Conclusions: This review uses a question-and-answer format to provide up-to-date, high-yield, clinically relevant information on myasthenia gravis.


  • Saved
Kearns-Sayre Syndrome Masquerading as Myasthenia Gravis : Retinal Cases and Brief Reports

Kearns-Sayre Syndrome Masquerading as Myasthenia Gravis : Retinal Cases and Brief Reports

Source : https://journals.lww.com/retinalcases/Abstract/9900/Kearns_Sayre_Syndrome_Masquerading_as_Myasthenia.130.aspx

sthenia gravis (MG). Methods: Case report. Results: A 15-year-old male with a presumed diagnosis of MG presented with blurry vision, ophthalmoplegia, and ptosis. He was found to have a mitochondrial...


Conclusions: We report a case of KSS found to have a novel large-scale mtDNA deletion. The presence of a mitochondrial pigmentary retinopathy found on dilated examination led to reconsideration of the previous diagnosis of MG and ultimately led to the correct diagnosis of KSS.